XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenues $ 862,412 $ 642,179
Costs and Expenses    
Cost of revenues (exclusive of depreciation shown below) 1,015,796 2,814,782
Research, development and manufacturing operations (exclusive of depreciation shown below) 2,794,641 4,820,536
Selling, general and administrative (exclusive of depreciation shown below) 3,244,793 5,598,004
Depreciation and amortization 377,306 1,193,535
Inventory impairment loss 0 363,377
Total Costs and Expenses 7,432,536 14,790,234
Loss from Operations (6,570,124) (14,148,055)
Other Income/(Expense)    
Other Income/(Expense), net 13,144 574,817
Interest Expense (7,351,681) (6,518,747)
Deemed interest expense on warrant liability 0 (345,774)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net (2,127,831) 1,877,629
Total Other Income/(Expense) (9,466,368) (4,412,075)
Net Loss $ (16,036,492) $ (18,560,130)
Net Loss Per Share (Basic and diluted) (in dollars per share) $ (0.69) $ (3.15)
Weighted Average Common Shares Outstanding (Basic and diluted) (in shares) 23,157,607 5,883,375